Guggenheim analyst Louise Chen lowered her price target on Valeant Pharmaceuticals (NYSE: VRX) to $195.00 (from $300.00) but maintained a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Valeant Pharma (VRX) May Be Seeing Real Institutional BuyingNovember 6, 2015 1:32 PM Is a 'Fire Sale' in Store for Valeant Pharma (VRX)?November 5, 2015 3:42 PM Worst Case Valeant (VRX) is a Buy - MizuhoNovember 5, 2015 3:13 PM Ackman, in email, says supports Valeant CEO PearsonNovember 5, 2015 2:43 PM Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBCNovember 5, 2015 2:14 PM Endo (ENDP) Defended at GuggenheimNovember 5, 2015 2:02 PM Valeant Pharma (VRX) Board Has Full Confidence in Mike Pearson - CNBCNovember 5, 2015 1:53 PM HedgEye says Valeant Pharma (VRX) may fall another 75%November 5, 2015 1:14 PM Streetinsider.com's Hot Lunchtime Reads 11/5: (VRX) (CAB) (QCOM) (BLRX) (RNWK)November 5, 2015 12:19 PM Three Reasons Valeant (VRX) is Plunging TodayNovember 5, 2015 12:02 PM BMO Capital Sees Valeant (VRX) Weakness Related to Ackman Comments that Pearson Might Have to GoNovember 5, 2015 11:47 AM Ackman backs Valeant CEO as shares tumble to 2-1/2 year lowsNovember 5, 2015 10:58 AM Valeant (VRX) In Free Fall as Large Holders May Finally Be Crying UncleNovember 5, 2015 10:42 AM Ackman Stocks Trade Lower on Valeant (VRX) Free-FallNovember 5, 2015 10:25 AM Valeant Pharma (VRX) Plunges Over 16%November 5, 2015 10:12 AM Valeant Pharma (VRX) Breaks Support at $88.50November 5, 2015 9:49 AM Wall St slips after mixed earnings as jobs report loomsNovember 5, 2015 7:31 AM VRX INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Securities Class Action Against Valeant Pharmaceuticals International, Inc.November 4, 2015 5:19 PM Valeant Pharma (VRX) At Lows Into the CloseNovember 4, 2015 3:43 PM